We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Spatial Biology – News and Features

News

MedImmune, 3M Drug Delivery Partner

The collaboration will focus on developing next generation toll-like receptor (TLR) agonists - promising agents that activate innate immune cells and enhance the visibility of cancer tumors.
News

Newly identified mechanism solves enduring mystery of key element of cellular organization

St. Jude Children’s Research Hospital scientists have discovered evidence of a mechanism at the heart of amyotrophic lateral sclerosis (ALS) and related degenerative diseases. The research appears in the journal Cell and highlights a possible new treatment strategy for the devastating disorders.
News

Compugen Discloses New Results Supporting CGEN-15052

Data presented at the Inaugural International Cancer Immunotherapy Conference in New York City.
News

Bar-Coding Technique Opens Up Studies Within Single Cells

Scientists have developed a method for simultaneously imaging and identifying dozens of molecules within individual cells.
News

Protein Aggregation After Heat Shock Is An Organized, Reversible Response

New study finds protein aggregation after heat exposure is a reversible cellular process, not unrecoverable damage from misfolding.
News

Inciting an Immune Attack On Cancer Cells

A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
News

AstraZeneca and Peregrine Pharmaceuticals to Collaborate

Collaboration on immuno-oncology combination clinical trial.
News

Inciting an Immune Attack on Cancer Cells

A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
News

AstraZeneca, Peregrine Pharmaceuticals Collaborate

Collaboration to Focus on Cancer Immunotherapy Combination of Peregrine's PS-Targeting Bavituximab and AstraZeneca's PD-L1 Inhibitor MEDI4736.
News

Statistical Technique Helps Researchers Understand Tumor Makeup, Personalize Cancer Treatments

A new statistical method for analyzing next-generation sequencing (NGS) data that helps researchers study the genome of various organisms such as human tumors and could help bring about personalized cancer treatments has been unveiled.
Advertisement